As of 28 Aug 2026, Jenburkt Pharmaceuticals Ltd share price is ₹1,030.55. The stock opened at ₹1,030.55 and had closed at ₹1,051.45 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹944.00 and a high of ₹1,321.00. In terms of performance, Jenburkt Pharmaceuticals Ltd share price has increased by 2.70% over the past six months and has decreased by 5.89% over the last year.
JENBURPH Charts
Jenburkt Pharmaceuticals Ltd Overview
About JENBURPH
Jenburkt Pharmaceuticals is in the business of manufacturing, producing, developing and marketing a wide range of branded Pharmaceuticals and health care products.
Jenburkt Pharmaceuticals Ltd Historical Performance
Jenburkt Pharmaceuticals Ltd Fundamental Analysis
Jenburkt Pharmaceuticals Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 37.02 | 48.98 | 44.84 | 47.64 | 37.59 |
| EBITDA | 7.54 | 14.65 | 9.25 | 15.18 | 11.01 |
| Net Profit | 5.89 | 10.85 | 5.93 | 10.16 | 7.79 |
| EPS | 13.34 | 24.58 | 13.44 | 23.03 | 17.66 |
Jenburkt Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 44.52 |
| MACD | -13.15 |
| 20-Day SMA | 1,070.32 |
Jenburkt Pharmaceuticals Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Jenburkt Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Jenburkt Pharmaceuticals Ltd today is ₹1,030.55 on NSE and ₹1,030.55 on BSE.
- The 52-week high of Jenburkt Pharmaceuticals Ltd is ₹1,321.00, while the 52-week low is ₹944.00.
- The current market capitalisation of Jenburkt Pharmaceuticals Ltd is approximately ₹455 crore.
- The P/E (Price-to-Earnings) ratio of Jenburkt Pharmaceuticals Ltd is 13.85. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Jenburkt Pharmaceuticals Ltd is 2.31. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Jenburkt Pharmaceuticals Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Jenburkt Pharmaceuticals Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Jenburkt Pharmaceuticals Ltd has delivered a return of approximately 45.78%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Jenburkt Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 46.62% promoters, 0.00% FIIs, 0.12% DIIs, and 41.05% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
